The aetiology of salivary gland malignancy is generally unknown, although exposure to ionizing radiation has been identified as a risk factor in humans (Modan et al., 1974; Hempelmann et al., 1975; Takeichi et al., 1976 ; National Academy of Sciences, 1980) . Geographic variation, with a high risk among Eskimos (Wallace et al., 1963; Lanier et al., 1976) and residents of Scotland (Lennox et al., 1978) , suggests other as yet unidentified factors. Experimental studies in mice have demonstrated a high risk of salivary gland malignancy after infection with polyoma virus (Gross, 1953) . Vitamin A deficiency has also been suggested to be a contributing factor from studies on rats (Rowe et al., 1970) . Berg et al. (1968) first drew attention to an excess risk of breast cancer in women who had had previous salivary gland malignancy and suggested that both cancers might have a common aetiology. However other studies have not confirmed the 8-fold excess risk found in the initial report, one reporting a much lower but still significant excess (Prior & Waterhouse, 1977) , while others reporting no significant increase (Moertel & Elveback, 1969; Dunn et al., 1972 A second primary cancer was defined as any invasive malignancy occurring 2 or more months after the diagnosis of the first primary. The diagnosis of the pathologist was accepted as correct, and no attempt was made to verify the diagnosis. Non-melanoma skin cancers and carcinoma-in-situ were excluded. Five malignancies occurring within 2 months of the diagnosis of the salivary gland primary (lymphoma, colon, prostate, nervous system and salivary of a different histology) were considered to be simultaneous primaries and excluded.
Person-years at risk were calculated from the date of diagnosis of the primary cancer to either date of diagnosis of the second primary, date of death, date lost to follow-up, or December 31, 1978, whichever occurred first. Expected numbers of second primary cancers were calculated by multiplying the age (5y-age groups), sex, calendartime and site-specific Connecticut cancer incidence rates by the appropriate person-years at risk (Monson, 1974) . Relative risks (RR) were computed using the ratio of observed to expected (O/E) cases and approximate 95% confidence intervals (C.I.) for the RR were computed assuming the observed number of cancers were distributed as a Poisson variable (Monson, 1974 Breast cancer among females occurred as a second primary in 7 patients, whereas 5.45 were expected (RR 1.3; 95% C.I. 0.5-2.7). The ages at diagnosis of salivary gland cancer in these women were 38, 41, 49, 65, 66, 67 and 86y. Interestingly, one male also developed cancer of the breast, whereas almost no cases (0.05) would be expected.
Four persons had 2 or more invasive separate primaries following salivary gland cancer. A 40y-old male had salivary followed by colon and male genital. A 60y-old female had salivary followed by colon and then breast. A 73 y-old female had salivary followed by lung and then melanoma; and an 89y-old female had salivary followed by ovarian and then corpus uteri and then bladder.
Discussion
The large number of person-years of follow-up and the careful calculation of age-and sex-specific expected incidence cases (adjusted for calendar-time of diagnosis) from the same population as the cases make this study especially useful. Despite this, we were unable to confirm a significant increase in risk of breast cancer, as has been reported by Berg et al. (1968) and by Prior & Waterhouse (1977) , but not found by Moertel & Elveback (1969) or Dunn et al. (1972) . (Table II) The small excess we observed was not statistically significant, but the relative risk of 1.3 fell within the confidence intervals of all earlier studies except that by Berg et al. (1968) .
Comparisons between studies are difficult, particularly with regard to computing the expected number of breast cancer cases. The most important variable affecting breast cancer incidence is the age of the cohort under follow-up, since breast cancer incidence increases with age. This in turn is a function of both age at entry into the study and duration of follow-up. We presume that the higher number of expected breast cancers calculated for the women in this study is related to the higher average age at entry into our study and the longer follow-up, but the data given in earlier reports are inadequate to document this precisely. Patients diagnosed as having their first salivary gland cancer at <60 y of age had no excess of breast cancer (O/E 3/3.25; RR 0.9). Thus there was no higher risk in women with a younger age at diagnosis of salivary gland cancer, as suggested by Prior & Waterhouse (1977) . Among women first diagnosed >60 y, the relative risk was 1.8 (O/E 4/2.25).
The excess of respiratory malignancies among males and ovarian cancer among females were significant. Bronchial cancer excesses were also observed in the study by Prior & Waterhouse (1977) . They raise the possibility that the excesses might be due to an underestimate of the expected number of bronchial cancers, since the rates of lung cancer changed dramatically over the period of their study but were averaged to provide an expected number. In our study the expected number was adjusted by the calendar-year the subject entered the study. No excess of ovarian cancer has been previously reported.
There are many reasons, in addition to chance, why excesses might occur. The aetiology of the tumours may share common environmental and/or genetic risk factors, as yet unknown. Smoking, for example, is a known risk factor in lung cancer, but it is apparently unrelated to the aetiology of a salivary gland cancer (Keller, 1969) . It is also possible that late, unrecorded therapy with other agents might have increased the risk of malignancy at other sites, as therapy was recorded only if it occurred within 4 mo of the diagnosis of the first primary malignancy.
Non-aetiologically related factors, such as misdiagnoses of metastatic disease and more complete tumour detection in patients being followed for a previous cancer, may also influence the excess risks observed in the follow-up group. As 4 respiratory and 2 ovarian second primary cancers occurred within 2y of the original salivary gland cancer, we suggest that these may be examples of nonaetiologically related tumours. If so, it is likely that there is no significant excess of second tumours following salivary gland primary cancer, at least that can be detected in a study of this size.
